In our cohort of APS, patients’ prior serology was noticeable for LAC detected in 84% and “triple positivity” (i.e. sero-positivity for aCL and a β2GP1 and LAC) in 55% of patients (Table 1). Here, ACLY is linked to autoimmune polyendocrinopathy.